Obokata, Naoyuki
Seki, Chie
Hirata, Takeshi
Maeda, Jun
Ishii, Hideki
Nagai, Yuji
Matsumura, Takehiko
Takakuwa, Misae
Fukuda, Hajime
Minamimoto, Takafumi
Kawamura, Kazunori
Zhang, Ming-Rong
Nakajima, Tatsuo
Saijo, Takeaki
Higuchi, Makoto
Funding for this research was provided by:
Mitsubishi Tanabe Pharma Corporation
Article History
Received: 13 November 2020
Accepted: 17 February 2021
First Online: 5 March 2021
Declarations
:
: Naoyuki Obokata, Takeshi Hirata, Takehiko Matsumura, Misae Takakuwa, Hajime Fukuda, Tatsuo Nakajima, and Takeaki Saijo are full-time employees of Mitsubishi Tanabe Pharma Corporation. Tatsuo Nakajima holds a patent for MTP38, MTP44, and MTP-X.
: All animal experiments were carried out in accordance with the Guide for the Care and Use of Laboratory Animals (National Research Council of the US National Academy of Sciences) and were approved by the Committee for the Care and Use of Laboratory Animals of National Institutes for Quantum and Radiological Science and Technology.